XML 47 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONVERTIBLE NOTES PAYABLE, NET (Tables)
12 Months Ended
Dec. 31, 2017
Debt Disclosure [Abstract]  
Schedule of convertible notes payable outstanding

Convertible notes consisted of the following as of December 31, 2017 and December 31, 2016:

 

    2017     2016  
The below section of convertible notes payable were all converted to common stock at $0.10 per share in connection with the January 2017 conversion agreements described in Note 6.                
                 
In June 2015, the Company issued 10% convertible notes with in the aggregate principal amount of $700,000. The notes are secured by the assets of the Company, matured in June 2017, and are convertible into common stock of the Company at a conversion rate of $0.03 per share, subject to adjustment. In connection with the issuance of these notes, the Company also issued warrants for the purchase of 15,400,000 shares of the Company’s common stock at an exercise price of $0.05 per share for a period of five years. The conversion rate on the notes and exercise price of the warrants were subject to adjustment for anti-dilution protection that requires these features to be bifurcated and presented as derivative liabilities. See Note 8. The Company also incurred debt issuance costs of $124,000, which are presented as a discount against the note and amortized into interest expense over the term of the notes. During the years ended December 31, 2016, a holder of a note elected to convert principal and accrued interest totaling $21,222 into 704,074 shares of common stock.   $     $ 680,000  
                 
In July 2015, the Company issued 10% convertible notes with in the aggregate principal amount of $190,000. The notes are secured by the assets of the Company, matured in July 2017, and are convertible into common stock of the Company at a conversion rate of $0.03 per share, subject to adjustment. In connection with the issuance of these notes, the Company also issued warrants for the purchase of 4,180,000 shares of the Company’s common stock at an exercise price of $0.05 per share for a period of five years. The conversion rate on the notes and exercise price of the warrants are subject to adjustment for anti-dilution protection that requires these features to be bifurcated and presented as derivative liabilities. See Note 6. The Company also incurred debt issuance costs of $16,200, which are presented as a discount against the note and amortized into interest expense over the term of the notes.           166,000  

  

In February 2016, the Company re-issued a 12% convertible note in the amount of $172,095. The note is secured by the assets of the Company, matured in September 2017, and is convertible into common stock of the Company at a rate of $0.10 per share. In connection with the issuance of this note, the Company issued warrants for the purchase of 1,146,667 shares of the Company’s common stock at an exercise price of $0.15 per share for a period of five years.           172,095  

 

In April 2016, the Company issued 12% convertible notes in the amount of $1,550,000. The notes are secured by the assets of the Company, mature in October 2017, and are convertible into common stock of the Company at a rate of $0.25 per share. In connection with the issuance of these notes, the Company also issued 1,033,337 shares of common stock and warrants for the purchase of 6,200,000 shares of the Company’s common stock at an exercise price of $0.25 per share for a period of five years. The conversion rate on the notes and exercise price of the warrants are subject to adjustment for anti-dilution protection that requires these features to be bifurcated and presented as derivative liabilities at their fair values. The Company also incurred debt issuance costs of $226,400, which are presented as a discount against the note and amortized into interest expense over the term of the notes. In August 2017, the Company entered into an agreement with the April 2017 Accredited Investors to reduce the exercise price on the embedded conversion features and warrants to $0.10 and increase the number of warrants to 15,500,000. The August 2017 change in terms of these Convertible Notes has been determined to be a loan extinguishment in accordance with ASC 470 Debt. The reported amounts under a loan extinguishment are not significantly different than that of the Company’s reported amounts.           1,550,000  
                 
Total Principal Outstanding   $     $ 2,568,095  
Less Current Maturities           (250,000 )
            2,318,095  
Unamortized Deferred Discounts           (6,466 )
Unamortized Debt Issuance Costs           (66,033 )
Notes Payable, Net   $     $ 2,245,596  
Schedule of convertible notes and related discounts

The following is a roll-forward of the Company’s convertible notes and related discounts for the years ended December 31, 2017 and 2016: 

 

      Principal
Balance
    Discounts
Issuance
Costs
    Debt
Discounts
    Total  
Balance at December 31, 2015   $ 1,038,095   $ (71,700 ) $ (583,049 ) $ 383,346  
New issuances     1,550,000     (226,400 )   (636,373 )   (687,227 )
Conversions     (20,000 )           (20,000 )
Amortization         232,067     1,212,956     1,445,023  
Balance at December 31, 2016     2,568,095     (66,033 )   (6,466 )   2,495,596  
                           
Conversions     (2,568,095 )           (2,568,095 )
Amortization         66,033     6,466     72,499  
Balance at December 31, 2017   $   $   $   $